Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cyclin E2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | cyclin B, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclin b3 | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclin B | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | cyclin, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | cyclins | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | cyclin family protein | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | cyclin B3 | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin D, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin B3, putative | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | cyclin, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Leishmania major | cyclin | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclin B3 1 | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin A, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclins, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclins | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclins, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclin B3 1 | 0.0021 | 0 | 0.5 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0021 | 0 | 0.5 |
Giardia lamblia | Cyclin A | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0021 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | cyclin 6, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclins, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | cyclin, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | NNMT/PNMT/TEMT family protein | 0.0855 | 1 | 1 |
Echinococcus granulosus | cyclin B | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclin b3 | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | cyclin B | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0021 | 0 | 0.5 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclins | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclins | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0855 | 1 | 1 |
Trypanosoma cruzi | cyclin, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin D, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | cyclins | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0855 | 1 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0021 | 0 | 0.5 |
Onchocerca volvulus | 0.0021 | 0 | 0.5 | |
Plasmodium falciparum | cyclin | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0021 | 0 | 0.5 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | cyclin family protein | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclins, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0021 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 13.5 uM | In vitro inhibitory activity against human cyclin dependent kinase (CDK2/E) | ChEMBL. | 11354366 |
IC50 (binding) | = 13.5 uM | In vitro inhibitory activity against human cyclin dependent kinase (CDK2/E) | ChEMBL. | 11354366 |
IC50 (functional) | = 15 uM | Inhibition SRB HCT 116 cancer cell proliferation | ChEMBL. | 11354366 |
IC50 (functional) | = 15 uM | Inhibition SRB HCT 116 cancer cell proliferation | ChEMBL. | 11354366 |
IC50 (binding) | = 24 uM | In vitro inhibitory activity against human cyclin dependent kinase (CDK4/D1) | ChEMBL. | 11354366 |
IC50 (binding) | = 24 uM | In vitro inhibitory activity against human cyclin dependent kinase (CDK4/D1) | ChEMBL. | 11354366 |
IC50 (binding) | = 35 uM | Inhibition of human cyclin dependent kinase 1 (CDK1/B) | ChEMBL. | 11354366 |
IC50 (binding) | = 35 uM | Inhibition of human cyclin dependent kinase 1 (CDK1/B) | ChEMBL. | 11354366 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 11354366 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.